Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

about

The role of laparoscopic surgery in the management of children and adolescents with inflammatory bowel disease.Functional outcomes and quality of life after restorative proctocolectomy in paediatric patients: a case-control study.

P2860

Q36193967-2BE5084B-8C83-4368-9291-D8F1FEA85728 Q37686614-C2A6A1FC-58BB-4982-9049-02D263D64282

P2860

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

Item

http://www.wikidata.org/entity/Q38022238

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

@en

type

Item

label

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

@en

prefLabel

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

@en

P1476

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

@en

P2093

Gia M Bradley

http://www.w3.org/2001/XMLSchema#string

Maria Oliva-Hemker

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Infliximab for induction and maintenance therapy for ulcerative colitis

Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study.

Presenting features of inflammatory bowel disease in Great Britain and Ireland.

Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.

Safety, efficacy, and pharmacokinetics of balsalazide in pediatric patients with mild-to-moderate active ulcerative colitis: results of a randomized, double-blind study.

Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab.

P304

125-134

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/BTT.S31833

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228082867

http://www.w3.org/2001/XMLSchema#string

P698

22740771

http://www.w3.org/2001/XMLSchema#string

P932

3379853

http://www.w3.org/2001/XMLSchema#string

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

about

P2860

P2860

Pediatric ulcerative colitis: current treatment approaches including role of infliximab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932